Meeting report: International workshop on endocrine disruptors: Exposure and potential impact on consumers health

Regulatory Toxicology and Pharmacology

Volumn 65, Issue 1, 2013, Pages 7-11

  Rousselle, C ^a   Ormsby, J N ^a,b   Schaefer, B ^b   Lampen, A ^b   Platzek, T ^b   Hirsch Ernst, K ^b   Warholm, M ^c   Oskarsson, A ^d   Nielsen, P J ^e   Holmer, M L ^e   Emond, C ^f,g  

^a FRENCH AGENCY FOR FOOD   (France)

^b FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^c Swedish Chemicals Agency   (Sweden)

^d SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^e The Danish Environmental Protection Agency EPA   (Denmark)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g Federal Institute for Risk Assessment Executive Office ^*  (Canada)

Author keywords

Consumers; Endocrine disruptors; Exposure scenarios; Methodology; Risk assessment

Indexed keywords

ENDOCRINE DISRUPTOR;

ACADEMIC ACHIEVEMENT; ARTICLE; COLD EXPOSURE; CONSENSUS SEQUENCE; CONSUMER; CONSUMER HEALTH INFORMATION; DOSE RESPONSE; HUMAN; MEDICAL SOCIETY; METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT;

EID: 84870943101     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.11.010     Document Type: Article

References (5)

1. Anses, 2011. Health effects of Bisphenol A: a collective expert report. Maisons-Alfort, France.
2. EFSA, 2010. Scientific Opinion on Bisphenol A: evaluation of a study investigating its neurodevelopmental toxicity, review of recent scientific literature on its toxicity and advice on the Danish risk assessment of Bisphenol A, Parma, Italy.
3. EU, 2009. Regulation (EC) No. 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing council directives 79/117/EEC and 91/414/EEC. Official Journal of the European Union L 309/1.
4. Klimisch H.J., Andreae M., Tillmann U. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharmacol. 1997, 25(1):1-5.
5. WHO, 2010. Characterization and application on physiologically based pharmacokinetic models in risk assessment. Harmonization Project Document No. 9, 1-97.